Bicycle Therapeutics
Quarterly Financials
| Values in thousands | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 |
|---|---|---|---|---|
Revenue | $47,955 | $11,734 | $2,920 | $9,977 |
Gross Profit | 12,897 | 11,734 | -68,109 | -47,294 |
EBITDA | -29,742 | -57,095 | -77,433 | -70,204 |
EBIT | -31,077 | -58,851 | -79,129 | -61,892 |
Net Income | -20,154 | -59,100 | -78,952 | -60,754 |
Net Change In Cash | 47,955 | 11,734 | 2,920 | 9,977 |
Free Cash Flow | -17,236 | -71,847 | -73,284 | -87,307 |
Cash | 628,110 | 648,325 | 721,451 | 792,972 |
Basic Shares | 69,279 | 69,303 | 69,252 | 69,196 |
Annual Financials
| Values in thousands | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 |
|---|---|---|---|---|
Revenue | $72,586 | $35,275 | $26,976 | $14,463 |
Gross Profit | 72,586 | -137,691 | -129,520 | 14,463 |
EBITDA | -276,861 | -164,892 | -183,400 | -107,208 |
EBIT | -283,298 | -172,069 | -189,946 | -110,897 |
Net Income | -218,960 | -169,031 | -180,664 | -112,717 |
Net Change In Cash | 72,586 | 35,275 | 26,976 | 14,463 |
Free Cash Flow | -252,613 | -165,959 | -63,557 | -105,098 |
Cash | 628,110 | 879,520 | 526,423 | 339,154 |
Basic Shares | 69,279 | 58,207 | 35,592 | 29,660 |
Earnings Calls
| Quarter | EPS |
|---|---|
2026-03-31 | $0 |
2025-12-31 | -$0.29 |
2025-09-30 | -$0.85 |
2025-06-30 | -$1.14 |
